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Introduction 
 
Fertility in many countries of sub-Saharan Africa (SSA) is falling[1],  although the rate of decline has 
been slower than most other world regions, and there is some evidence to suggest that fertility decline 
has plateaued in some countries[2]. Fertility is influenced by child-bearing desires, contraceptive use 
and maternal health.  In SSA, increases in women’s education and employment opportunities, access 
to contraception, and changes in societal and individual opinions regarding delaying child-bearing in 
unstable or uncertain periods are thought to have influenced fertility trends[3].  In many SSA countries 
the HIV epidemic has had negative impacts on health and family stability with consequences for 
fertility[4–6].   
 
The effect of HIV on fertility is complex.  HIV and fertility are positively associated in adolescents, as 
women who have unprotected sex have higher risk of both HIV acquisition and pregnancy[7].  
However, older HIV-positive women have lower fertility rates than HIV-negative women[4,7]. HIV 
infection has been shown through biological pathways to reduce the ability to conceive and bear a live 
child[8–12].  Social and behavioural factors are also related to lower fertility in HIV-positive women, 
due to altered child-bearing desires[11,13–16] and likelihood of being in a relationship[17].   In Malawi 
and other high HIV-prevalence countries, widespread availability of antiretroviral treatment (ART), has 
removed many of the biological barriers to fertility by improving health and survival of women and 
their partners[18,19], which has been shown to increase people’s desire for children[20,21] although 
this may not correlate with actual fertility[22].  There is, however, still uncertainty surrounding the 
impact of increased access to ART on fertility in HIV-positive women[23]. 
  
Malawi has adopted a public health approach[24] to its HIV epidemic with sector-wide policies to 
maximise ART uptake in HIV-positive people, including Option B+[25]: from July 2011 all pregnant and 
breast-feeding women were eligible for life-long ART regardless of immunological status; and in 2016, 
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universal ART eligibility was introduced so all HIV-positive people should be offered ART at the time 
of testing[26]. Prior to Option B+, prevention of mother to child transmission (PMTCT) programmes 
involved HIV-testing for pregnant women and short-courses of ART, taken until completion of breast-
feeding[27].  Since 2011, the guidelines in Malawi have promoted provider-initiated family planning 
but specifically stated that “Health workers should not actively discourage pregnancy” in HIV-positive 
women[28]. 
 
Studying trends in fertility is important as it enables long-term planning for services required for 
pregnant women, and their children at various stages in their lives.  In Malawi, infants born to HIV-
positive mothers should be monitored until aged 24-months, which presents a burden to an already 
stretched health service, and retention in this programme is not always optimal[29]. Reducing the 
number of children born with HIV would reduce the burden on the health system once they were 
older, but there is little evidence regarding the long-term effects of exposure to ART in utero or 
through breastfeeding, especially in rural African contexts[30]. If the expansion of the ART programme 
is accompanied by increasing fertility in women on ART, there will be a concomitant increase in the 
number of infants requiring monitoring and testing for HIV, and an increasing number of ART-exposed 
children whose future health needs are currently uncertain. 
 
In this study, we use data from a rural longitudinal cohort in northern Malawi, to explore temporal 
fertility trends and the association of HIV-infection and ART availability with fertility. We also describe 
temporal trends in HIV- and ART-exposure in infants. 
 
Methods 
 
Population and data 
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Population: The Karonga Health and Demographic Surveillance Site (HDSS), established in 2002, 
captures information on births, deaths, and in- and out-migrations, in a  population of about 39,000 
people (including 9000 women aged 15-49) living in a 150km2 rural area of Northern Malawi[31]. The 
HDSS has also collected socio-economic information, including highest attained education-level and 
marital status, from annual surveys since 2007.  In 2007-2008 the adult HIV prevalence was 6.3% in 
males and 8.5% in females, and estimated ART coverage was 48% in males and 65% in females in 2008-
10[32]. 
 
HIV test data:  Within the HDSS, population-level HIV testing and counselling in adults 15 years and 
older were done in multiple sero-surveys, starting with randomly selected clusters in 2005-06 and 
followed by four successive HIV sero-surveys across the whole population, from 2007 to 2011.  
Interviewers asked about previous HIV testing (available from several providers in the area), including 
the timing and result of the most recent test (positive negative, unknown). Each sero-survey used a 
standardised rapid test protocol; results were immediately available to the participant[33] and  the 
vast majority (>90%) of people consented to be informed of their result.  Within the HDSS, HIV testing 
(with disclosure to participants) has also been offered in some smaller research studies conducted 
from 1988 onwards. We include these HIV test data in this analysis if the study was population-
representative and not limited to select groups (e.g. clinically symptomatic people). 
 
For our analysis we assigned HIV-positive status from one year prior to their first positive test-date (or 
from the mid-point between the last negative test and the first positive, if that interval was one year 
or shorter).  To be comparable with the HIV-positive women, we assigned women as HIV-negative 
from one year before their first negative test-date (self-report or study), and up to four years after 
their last negative test-date (due to relatively low incidence rates in the area, and length of time since 
the last sero-survey) unless they had a subsequent positive test during this time.  All other time was 
classified as ‘unknown’.  Infants were categorised as HIV-exposed if their mothers were identified as 
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HIV-positive at any time up to one year after their birth (assuming that they would have been breast-
fed for at least one year). 
 
ART use data: ART was available at the main hospital (which is 70km from the HDSS area and largely 
inaccessible to the HDSS population) from June 2005, at the rural hospital within the HDSS area from 
September 2006, and at smaller clinics in the area from October 2010.  Data on uptake of HIV services 
were collected via links with local clinics: by identifying and tracking cohorts of consenting people 
initiated on ART, capturing current and previous ART usage[34].  We assigned women as not (yet) on 
ART from one year before their first positive test (i.e. from the point we assigned them as HIV-positive) 
up to their first ART start-date (self-reported or clinic) or up to two years after the last date they are 
known to have never taken ART.  We assigned women as on ART from their first ART start-date (self-
reported or clinic) up to their last ART stop-date (self-reported or clinic) or up to three months after 
the last date they are known to still be taking ART (assuming they took their final prescription). Infants 
were categorised as ART-exposed if their mothers were on ART at any time up to one year after their 
birth (assuming that they would have been breast-fed for at least one year).   
 
Statistical methods 
 
We conducted a longitudinal analysis, including person years for the period of follow-up for the entire 
population of women aged 15-49 and all live-births (with multiple births contributing separately) born 
to these women between 2005 and 2014.  We examined fertility trends over three periods of ART 
availability: 2005-6 [no/little ART in the HDSS area], 2007-10 [ART roll-out] and 2011-14 [ART widely 
available] in the following ways: 
1. We calculated age-specific fertility rates by HIV/ART status.  We then used these age-specific 
rates to calculate the total fertility rate (TFR): a summary measure of the average number of 
children that would be born per woman if they were to complete child-bearing years 
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experiencing the current age-specific rates.  We also used Cox proportional hazards regression 
models to compare fertility rates in HIV-positive women on ART or not (yet) on ART to those 
of HIV-negative women, with adjustment for age (in 5-year age-bands), marital status (never 
married, married, divorced, widowed) and educational level (none, primary standards 1-3, 
primary standards 4-7, primary completed, 2 years of secondary, 4 years of secondary).  
Option B+ has resulted in relatively healthy women initiating ART due to pregnancy; to avoid 
this artificially raising the apparent fertility of women on ART we only included women who 
had been on ART for at least 9 months (excluding 102 births where the mother started ART 
during pregnancy, and 486.3 person years).  Subsequent births to Option B+ women were 
included.   
2. We calculated crude and age-specific fertility rates by number of years on ART (excluding less 
than one year due to above described issue of women starting ART in pregnancy, and 
combining 4 years and above due to the small number of births in younger women).    
3. We calculated the number and proportion of infants who were HIV- and ART-exposed in the 
three periods, and the proportion exposed to ART from the first trimester of pregnancy until 
at least delivery (calculated by estimating the conception date as nine months prior to the 
birth-date). 
 
 
Results 
 
From 2005 to 2014 there were 13,583 live-births during approximately 78,000 person years of follow-
up of women aged 15-49.  Overall, the TFR was 5.2 (95% CI=4.9-5.4), declining from 6.0 (5.4-6.6) in 
2005-06 to 4.6 (4.3-4.9) in 2011-14 (table 1).  The highest crude fertility rates were in the 20-24 year 
age group (270.7 per 1000 person years [262.5-279.2]), in married women (226.2 per 1000 [221.8-
230.7]), and in women with 4-7 years of education (excluding unknown education category) (182.6 
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per 1000 [177.6-187.7]) (table 1).  There were 9,391 births to HIV-negative women and 626 births to 
HIV-positive women (158 on ART for at least 9 months, 294 not on ART, 102 started ART during 
pregnancy and 72 unknown) (table 1).  Of the 1294 women reported to be HIV-positive during the 
analysis, 738 (57.0%) had their first HIV-positive test-date derived from clinic or HIV test data and 556 
(43.0%) from self-reported data.  Of the 745 women reported to be on ART at any point during the 
analysis, 380 (51.0%) had the first ART initiation date derived from clinic data and 365 (49.0%) from 
self-reported data. 
 
Fertility rates in HIV-positive vs. HIV-negative women 
From 2005-06 to 2011-14, there was a downward trend in the TFR of HIV-negative women (6.1 [4.6-
8.1] to 5.1 [4.8-5.5]). In HIV-positive women there was an increase from 3.7 (1.7-8.4) in 2005-06 to 4.3 
(3.2-6.0) in 2007-10.  However, it remained stable up to 2011-14 when it was 4.4 (3.2-6.1) (table 2).  
The TFR in women with unknown HIV-status decreased more sharply than in the HIV-negative women, 
from 6.1 (5.5-6.8) to 2.8 (2.1-4.0); this was due to a fall in the number of births born to women with 
unknown HIV-status (669 in 2007-10 vs. 371 in 2010-14) which was not reflected in a decrease in the 
number of person years (4300.9 in 2007-10 vs. 4919.6 in 2010-14). 
 
Fertility rates in HIV-positive women on ART vs. HIV-positive women not on ART 
The pattern of age-specific fertility rates in women on ART for at least 9 months changed from 2007-
10 to 2011-14.  In the earlier period, rates in younger women were lower than those of women not 
on ART while in the later period they were higher, and more similar to those of HIV-negative women.  
However, confidence intervals were wide: the fertility rate in the 20-24 year group on ART at least 9 
months was 146.5 per 1000 [47.3-454.3] in 2007-10, and 316.0 per 1000 (175.0-570.6) in 2011-14.  
Rates in older women in both periods were similar in women on, and not (yet) on ART (figure 1). 
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The TFR in HIV-positive women on ART for at least 9 months in 2011-14 was 3.7 (2.2-7.1), which was 
similar to that of women not on ART (3.8 [2.1-7.3]) (table2).  Compared to HIV-negative women, HIV-
positive women experienced lower adjusted hazards for a live-birth throughout follow-up and there 
was little evidence of a difference between women on ART for at least 9 months, and not (yet) on ART:  
in 2011-14 the adjusted hazard ratios were 0.7 (0.6-0.9) and 0.8 (0.6-1.0), respectively (table 3).  The 
TFR in women who started ART during pregnancy was high and increased over time.  The rates for 
women with unknown ART status were higher than those known not to be on ART, however the 
numbers of births and person years in both these categories were small (table 2). 
 
Fertility rates in HIV-positive women, by years on ART 
Crude fertility rates increased with years since ART initiation, from 65.4 per 1000 (46.5-91.9) in women 
on ART for one year, to a peak of 94.0 per 1000 (95% CI 66.8-132.3) in women who had been on ART 
for three years.  The rate in women on ART for four or more years was lower at 64.8 per 1000 (49.4-
85.0).  This pattern was observed in the 20-29 year age group, and, at lower levels, in the 30-49 year 
group (table 4).  
 
Exposure to ART in utero and breast-feeding 
The proportion of infants who were HIV-exposed decreased slightly from 5.8% (313/5435) in 2007-10 
to 5.2% (271/5255) in 2011-14.  The proportion exposed to ART increased, however, from 2.4% 
(83/5435) to 3.5% (185/5255).  In 2011-14, 2.5% (n=134) of all live-births were reported to have been 
exposed to ART from the first trimester of pregnancy up to delivery. 
 
Discussion 
 
Our findings from rural Malawi show that from 2005 to 2014, during increasing availability of ART, the 
total fertility rate declined overall and in HIV-negative women, while remaining stable and lower in 
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HIV-positive women. There was a suggestion of an increase in fertility levels in younger women on 
ART, and fertility levels increased with time on ART (up to peak at 3 years since initiation), however, 
there was little overall difference in fertility in women on ART for at least 9 months and women not 
(yet) on ART.  Nonetheless, despite lack of evidence for increasing fertility in HIV-positive women at 
the population level, the proportion of infants exposed to ART has increased. 
 
The overall decrease in fertility in our HDSS is consistent with the level of fertility decline shown in the 
2010 Malawian Demographic and Health Survey, which reported a TFR of 5.7 for the northern region, 
which compares well to our figure of 5.4 in 2007-10[35].  Our findings of increased fertility rates in 
HIV-positive women, although lower than HIV-negative women during the era of widespread ART 
availability is consistent with those of a systematic review of recently published studies[23].  Evidence 
for an effect of duration of ART on fertility is inconsistent: some studies report no difference while 
others, including ours, report increasing fertility rates with increased duration of ART[23]. 
 
The lower fertility rates in younger women on ART in the early period of ART-availability in our data 
may be because ART was initially provided to the sickest (and presumably least fertile) individuals, 
with treatment extending to individuals at an earlier stage of disease over time.  Recently, movement 
of HIV-positive women onto ART at an earlier stage of disease, may explain the similar fertility levels 
in women on ART and those not (yet) on ART (who are yet to experience fertility effects of poor 
health).  Prolonged use of ART may itself have biological effects on fertility which may explain the 
lower fertility levels of HIV-positive women on ART compared to HIV-negative women, and that even 
in younger women, fertility rates in women on ART for four or more years are lower than those in 
women on ART for three years. There is evidence to suggest that some anti-retroviral drugs have an 
adverse effect on gametes[8], although the effect of ART on male fertility is unclear[36,37].  Early 
evidence on the impact of ART on birth outcomes is inconsistent, with some studies showing no 
effect[38], while others report increased pre-term births[39]. 
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Fertility dynamics are also affected by child-bearing desires.  While evidence suggests that HIV-positive 
women are less likely to want more children than HIV-negative women[15], a study of nine SSA 
countries found no consistent pattern in changing fertility desires during increasing coverage of 
ART[16].  Although guidelines recommend that HIV-positive women are not actively discouraged from 
becoming pregnant[40], HIV-positive women in Malawi reported no, or discouraging discussions 
about child-bearing with health-care workers[41]; this was confirmed by health-care workers in the 
same area who had mixed attitudes around child-bearing in HIV-positive women, with several actively 
discouraging women[42].  Community stigma against child-bearing in HIV-positive women may also 
explain why fertility levels in HIV-positive women are not the same as those in HIV-negative women. 
 
Excluding women who start ART during pregnancy was necessary to examine the effect of ART on 
fertility, as many of these women would have only started ART due to the pregnancy while healthy 
and the treatment would have had no effect on the conception and live-birth of the child (so including 
them would inflate the observed effect of ART).   Nonetheless it is also plausible that ART could have 
reduced the chance of a miscarriage or, greater knowledge of ART availability with the introduction of 
Option B+ may have encouraged HIV-positive women/couples to bear a child when otherwise they 
might not have; therefore it is possible that we have underestimated the effect of ART on fertility in 
the population. 
 
We found a reduction in the number of HIV-exposed infants in recent years but, mainly due to the 
Option B+ policy, an increasing number of infants exposed to ART for the entire pregnancy, which may 
have important implications for the immediate and future health care needs of these children. In 
Malawi, maternal HIV-exposure remains an important risk factor for infant morbidity and 
mortality[43] and there is evidence that HIV-exposed, but uninfected infants have a higher risk of 
morbidity and mortality, perhaps due to a greater likelihood of immune dysfunction and/or low birth-
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weight[39,44,45].  Few adverse effects of in utero ART have been found in developed settings[46–48] 
but the short- and long-term effects of this exposure in populations where pregnancy nutrition is sub-
optimal and mothers are exposed to multiple infections are not well described[30,49,50].  Longer 
follow-up with longitudinal studies of children exposed to ART are needed to understand better the 
longer-term sequelae of this early life exposure.  
 
Incomplete data on HIV-status and ART use is a limitation of our study.  We found different patterns 
in fertility rates in women with unknown HIV-status, however as their status is unknown to the 
research team, this group will represent women who truly do not know their current HIV status (never 
tested or received results from a test) and those who know but were unwilling to disclose.  In Malawi 
opt-out HIV-testing is routinely offered in ante-natal care hence it is likely that women who have had 
a birth are more likely to know their status than women who have not.  These factors make it difficult 
to interpret the fertility rates in women with unknown status. Exclusion of women who started ART 
during pregnancy further reduced our sample size in this category, making interpretation of fertility 
trends a challenge: for example although there appeared to be an increase in fertility rates in young 
HIV-positive women on ART, the confidence limits were wide, which may have been due to a small 
number of women in this category.  However, use of high-quality HDSS data means that we achieved 
high ascertainment of all live-births and use of HIV-test data from population-based HIV sero-surveys, 
with high participation rates (73-83%), will have minimised the potential for selection bias regarding 
HIV-status. We do not capture information on ART care from clinics outside of the HDSS area, so this 
could introduce bias if seeking care outside of the area was associated with fertility.  Inaccuracies in 
ART start- and stop-dates within clinic registers may have introduced some misclassification of 
women’s exposure.  We have assigned women to be HIV-positive for one year before their first 
positive test, due to the assumption that most people will have sero-converted long before they test.  
One year could be a conservative estimate and, with increasing access to HIV-testing, it is likely that 
the length of time between sero-conversion and testing positive will have changed over time.  Without 
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access to gestational age at birth we have assumed each pregnancy to have lasted nine months. This 
may have resulted in exclusion of some women who started ART before pregnancy but experienced a 
pre-term birth, for which HIV-infection and ART increase risk, thereby further attenuating fertility 
estimates in this group.  Finally, although we attempted to control for factors known to be associated 
with both HIV-status, ART-usage and fertility (education, marital status and age), some of these data 
were missing, and there may be other unmeasured factors confounding the observed associations. 
 
Conclusion 
 
In rural Malawi with widespread access to ART, despite decreasing overall fertility levels, fertility rates 
in HIV-positive women remain stable.  Even without fertility levels in HIV-positive women matching 
those of HIV-negative women, the number of ART-exposed infants born has increased and is likely to 
continue to do so with continued implementation of the Option B+ PMTCT strategy.  In this resource-
constrained setting determining and addressing the potential immediate and long term health care 
needs of an increasing number of ART-exposed infants, may be a challenge. 
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Figure 1: Age-specific fertility rates by HIV/ART status and era of ART availability  
 
Table 1: Number of births, person years, crude fertility rate and total fertility rate by demographic and 
HIV/ART variables, 2005-2014 
 
Table 2: Total fertility rate (and number of births) by HIV/ART status and year 
 
Table 3: Hazard ratio of live-birth event controlling for age, marital status and education level* in HIV-
positive women compared to HIV-negative women, by ART usage and year 
 
Table 4: Fertility rates in HIV-positive women on ART, by years since ART initiation 
